摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-Naphthylsulfonyl)-4-(4-nitrophenyl)piperazine

中文名称
——
中文别名
——
英文名称
1-(2-Naphthylsulfonyl)-4-(4-nitrophenyl)piperazine
英文别名
1-naphthalen-2-ylsulfonyl-4-(4-nitrophenyl)piperazine
1-(2-Naphthylsulfonyl)-4-(4-nitrophenyl)piperazine化学式
CAS
——
化学式
C20H19N3O4S
mdl
MFCD00758150
分子量
397.4
InChiKey
UFHCEZWFXJZECH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    28
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    94.8
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    1-(2-Naphthylsulfonyl)-4-(4-nitrophenyl)piperazine噻吩 氢气异丙醇 作用下, 以 四氢呋喃 为溶剂, 以yielding 2.39 g (87%) of 1-(4-aminophenyl)-4-(2-naphthalenylsulfonyl)-piperazine (interm. 7)的产率得到1-(4-Aminophenyl)-4-(2-naphthalenylsulfonyl)-piperazine
    参考文献:
    名称:
    SULFONYL-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE
    摘要:
    本发明涉及具有组式(I)的新型化合物,其中n,m,t,R1,R2,R3,R4,L,Q,X,Y,Z和具有定义的含义,具有组蛋白去乙酰化酶抑制酶活性;它们的制备,含有它们的组合物以及它们作为药物的用途。
    公开号:
    US20120088754A1
点击查看最新优质反应信息

文献信息

  • [EN] SULFONYL-DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] DERIVES DE SULFONYLE UTILISES COMME INHIBITEURS DE L'HISTONE DEACETYLASE
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2003076422A1
    公开(公告)日:2003-09-18
    This invention comprises the novel compounds of formula (I) wherein n, m, t, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
    本发明涉及一种新型化合物,其化学式为(I),其中n,m,t,R1,R2,R3,R4,L,Q,X,Y,Z均有定义的含义,具有组蛋白去乙酰化酶抑制酶活性;它们的制备,含有它们的组合物以及它们作为药物的用途。
  • Sulfonyl-Derivatives as novel inhibitors of histone deacetylase
    申请人:Van Emelen Kristof
    公开号:US20050113373A1
    公开(公告)日:2005-05-26
    This invention comprises the novel compounds of formula (I) wherein n, m, t, R 1 , R 2 , R 3 , R 4 , L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
    本发明涉及具有组合式(I)中所定义的n,m,t,R1,R2,R3,R4,L,Q,X,Y,Z的新型化合物,具有组蛋白去乙酰化酶抑制酶活性;它们的制备,含有它们的组合物以及它们作为药物的用途。
  • Sulfonyl-Derivatives as Novel Inhibitors or Histone Deacetylase
    申请人:Van Emelen Kristof
    公开号:US20080108601A1
    公开(公告)日:2008-05-08
    This invention comprises the novel compounds of formula (I) wherein n, m, t, R 1 , R 2 , R 3 , R 4 , L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
    这项发明包括具有组成式(I)的新化合物,其中n,m,t,R1,R2,R3,R4,L,Q,X,Y,Z和具有定义的含义,具有组蛋白去乙酰化酶抑制酶活性;它们的制备,含有它们的组合物以及它们作为药物的用途。
  • Sulfonyl-Derivatives as Novel or Histone Deacetylase
    申请人:Van Emelen Kristof
    公开号:US20100240639A1
    公开(公告)日:2010-09-23
    This invention comprises the novel compounds of formula (I) wherein n, m, t, R 1 , R 2 , R 3 , R 4 , L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
    这项发明涉及公式(I)的新型化合物,其中n、m、t、R1、R2、R3、R4、L、Q、X、Y、Z和具有定义的含义,具有组蛋白去乙酰化酶抑制酶活性;它们的制备,含有它们的组合物以及它们作为药物的用途。
  • Sulfonyl-derivatives as novel or histone deacetylase
    申请人:Janssen Pharmaceutica, N.V.
    公开号:US08097611B2
    公开(公告)日:2012-01-17
    This invention comprises the novel compounds of formula (I) wherein n, m, t, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
    本发明涉及式(I)的新化合物,其中n,m,t,R1,R2,R3,R4,L,Q,X,Y,Z和具有定义的含义,具有组蛋白去乙酰化酶抑制酶活性;它们的制备,含有它们的组合物以及它们作为药物的用途。
查看更多